drugset / Trial / NCT03003039
A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is the area under the curve (AUC) for GB241 and rituximab concentrations.
Timeline
- Start
- 2017-06-05
- Primary completion
- 2019-05-20
- Completion
- 2019-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GB241 | Unknown | 375 mg/m2 | Intravenous |
| Comparator | Rituximab | Monoclonal antibody | 375 mg/m2 | Intravenous |